Leal Therapeutics
Develops neuro-metabolic therapeutics for schizophrenia and ALS
$30MSeries A
Role not disclosedSH
SV Health Investors' Dementia Discovery Fund
Activity from announced rounds
Activity in this selectiontvc-the-venture-collective-e3967f14
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $30M 1 disclosed · full round size, not this investor’s share